دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
May Mediterranean diet contribute to reduce risk of multiple sclerosis?
Paola Cavalla and Marco Vercellino
doi : 10.1177/13524585231190342
Volume 29 Issue 9, August 2023
Commentary: Solomon AJ et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol 2023; 22(8): 750–768
Jeffrey A Cohen
The Barancik lecture: Comorbidity in multiple sclerosis�Looking backward, looking forward
Ruth Ann Marrie
Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
Richard W Titball , Nicholas Lewis and Richard Nicholas
Quality of life should be the primary outcome for disease-modifying therapy trials in MS�Yes
Yael Goverover and Nancy Chiaravalloti
Quality of life should be the primary outcome for disease modifying therapy trials in MS�No
EMM Strijbis , MW Koch and BA de Jong
Quality of life should be the primary outcome for disease-modifying therapy trials in MS: Commentary
Gavin Giovannoni
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
Xiaotong Jiang, Changyu Shen, Charlotte E Teunissen, Mark Wessels , Henrik Zetterberg, Gavin Giovannoni, Carol M Singh, Bastien Caba, Colm Elliott , Elizabeth Fisher*, Carl de Moor, Shibeshih Belachew and Arie R Gafson
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease
Itay Lotan , John J Chen, Yael Hacohen, Omar Abdel-Mannan, Sara Mariotto, Saif Huda, Emily Gibbons, Adi Wilf-Yarkoni, Mark A Hellmann, Hadas Stiebel-Kalish, Sean J Pittock , Eoin P Flanagan , Negar Molazadeh , Monique Anderson, Rebecca Salky, Gabriela Romanow, Patrick Schindler, Ankelien Solveig Duchow, Friedemann Paul and Michael Levy
Sars-CoV2 infection in pregnant women with multiple sclerosis
Maria Grazia Aprea* Irene Schiavetti* , Emilio Portaccio , Chiara Ballerini, Mario Alberto Battaglia, Roberto Bergamaschi, Giampaolo Brichetto , S Destan Bunul, Massimiliano Calabrese, Marco Capobianco, Paola Cavalla, Maria Grazia Celani, Marinella Clerico, Eleonora Cocco , Giancarlo Comi, Paolo Confalonieri, Antonella Conte, Cinzia Cordioli, Giovanna De Luca, Nicola De Rossi, Massimo Filippi , Haluk Gumes, Paolo Immovilli, Matilde Inglese, Rana Karabudak, Doriana Landi, Roberta Lanzillo, Maria Rita L’Episcopo, Lorena Lorefice, Vittorio Mantero , Sabrina Marangoni, Girolama Alessandra Marfia, Camilla Masciulli, Eva Milano, Lucia Moiola , Riccardo Orlandi , Francesco Patti , Paola Perini, Ilaria Pesci, Eugenio Pucci, Marco Puthenparampil , Marta Radaelli, Marco Salvetti , Arianna Sartori, Cinzia Scandellari, Sedat Sen , Aksel Siva , Silvia Strumia, Francesco Teatini, Gioacchino Tedeschi, Maria Trojano, Melih Tutuncu, Giovanna Vaula, Maria Pia Sormani* and Maria Pia Amato * ; Musc-19 Study Group
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study
Mikael Cohen , Océane Thommel Rocchi, Aksel Siva , Darin T Okuda , Rana Karabudak, Hüsnü Efendi, Murat Terzi, Clarisse Carra-Dalliere , Francoise Durand-Dubief, Eric Thouvenot , Jonathan Ciron , Helene Zephir, Bertrand Bourre, Olivier Casez, Jérôme De Seze, Thibault Moreau, Jean-Philippe Neau, Daniel Pelletier, Orhun Kantarci, Melih Tutuncu, Nathalie Derache, Caroline Bensa, Celine Louapre, Jeanne Benoit, Cassandre Landes-Chateau and Christine Lebrun-Frenay ; on behalf of RISC* and Turkish RIS Study Group**
Assessing everyday functional activity in cognitively impaired people with multiple sclerosis: The use of Actual RealityTM
Yael Goverover , Amber Salter and John DeLuca
Inverse association between Mediterranean diet and risk of multiple sclerosis
Lars Alfredsson, Tomas Olsson and Anna Karin Hedstr?m
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
Anna H He , Ali Manouchehrinia , Anna Glaser, Olga Ciccarelli, Helmut Butzkueven, Jan Hillert and Kyla Anne McKay
Improving the efficiency of clinical trials in multiple sclerosis
Ruth Ann Marrie , Maria Pia Sormani , Sean Apap Mangion, Francesca Bovis, Winson Y Cheung, Gary R Cutter , Peter Feys, Michael D Hill, Marcus Werner Koch , Morgan McCreary , Ellen M Mowry, Jay JH Park, Fredrik Piehl , Amber Salter and Jeremy Chataway; on behalf of the participants in the International Conference on Innovations in Clinical Trial Design & Enhancing Inclusivity of Clinical Trial Populations
Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review
Marcia Finlayson , Leyan Al-Mashita and Rebekah Sandhu
Assessing heterogeneity of treatment effect in multiple sclerosis trials
Maria Pia Sormani , Jeremy Chataway, David M Kent and Ruth Ann Marrie ; On Behalf of the Participants in the International Conference on Innovations in Clinical Trial Design & Enhancing Inclusivity of Clinical Trial Populations
Enhancing involvement of people with multiple sclerosis in clinical trial design
Emma Gray*, Anneesa Amjad*, Jenny Robertson , Judy Beveridge, Susan Scott, Guy Peryer, Marie Braisher , Cheryl Pugh , Sara Peres, Ruth Ann Marrie , Maria Pia Sormani and Jeremy Chataway; on behalf of OCTOPUS investigators, the participants in the International Conference on Innovations in Clinical Trial Design & Enhancing Inclusivity of Clinical Trial Populations
Enhancing diversity of clinical trial populations in multiple sclerosis
Ruth Ann Marrie , Jeremy Chataway, Barbara E Bierer, Marcia Finlayson , Elena H Martinez-Lapiscina, Jennifer Panagoulias, Maria Pia Sormani , Mitzi Joi Williams and Lilyana Amezcua ; On Behalf of the Participants in the International Conference on Innovations in Clinical Trial Design & Enhancing Inclusivity of Clinical Trial Populations
Intermediate outcomes for clinical trials of multiple sclerosis rehabilitation interventions: Conceptual and practical considerations
Marcia Finlayson , Peter Feys, Ulrik Dalgas and Daphne Kos ; On behalf of the participants in the International Conference on Innovations in Clinical Trial Design & Enhancing Inclusivity of Clinical Trial Populations
Coexistence of multiple sclerosis and spinocerebellar ataxia type-8
Nur Neyal , B Mark Keegan , Orhun H Kantarci and Burcu Zeydan
